Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
SK pharmteco appoints Joerg Ahlgrimm as CEO to spearhead the next phase of company growth and innovation 2022-11-02 02:00
Henlius' Novel Anti-PD-1 mAb HANSIZHUANG (Serplulimab) Receives NMPA Approval for the Treatment of sqNSCLC 2022-11-01 21:32
Hummingbird Bioscience to Attend the Credit Suisse 31st Annual Healthcare Conference 2022-11-01 20:00
Karyopharm and Menarini Group Announce Orphan Medicinal Product Designation from the European Commission for Selinexor for the Treatment of Myelofibrosis 2022-11-01 19:40
Citeline and Norstella Complete Merger to Form a $5 Billion Global Pharmaceutical Technology Company 2022-11-01 19:00
Pervistop®, the once-daily supplement specifically designed to manage persistent HPV, is now available for exclusive distribution rights worldwide. 2022-11-01 16:00
Gerresheimer AG and Stevanato Group present EZ-fill Smart™, a new and innovative Ready-To-Fill Vial Platform 2022-11-01 15:00
RemeGen Releases Phase II Clinical Study Data for Treatment of Myasthenia Gravis in Chinese Patients 2022-11-01 12:12
Codex Genetics to Offer Guardant Health's Precision Oncology Tests in Hong Kong and Macau 2022-11-01 11:21
Antengene Receives U.S. FDA Clearance of IND Application for Phase I Trial of Small Molecule ERK1/2 Inhibitor ATG-017 in Patients with Advanced Solid Tumors 2022-10-31 20:22
Xinhua Silk Road: Cloud + offline fair injects new vitality into National TCM Materials & Pharmaceuticals Trade Fair 2022-10-31 19:00
Samyang Holdings' Lafullen Makes Splash in Korean Medical Aesthetics Market 2022-10-31 08:00
Innovent Announces First Patient Dosing in Australia in Phase I Study of IBI343 (Recombinant anti-Claudin18.2 Monoclonal Antibody-drug Conjugate) in Patients with Advanced Solid Tumors 2022-10-31 08:00
World Stroke Organization Tackle Gaps in Access to Quality Stroke Care 2022-10-29 06:01
Hinova Disclosed the Preclinical Results of HP518 (Oral AR PROTAC) at the 5th Annual TPD Summit 2022-10-29 05:30
Pharming Announces European Medicines Agency (EMA) Validates its Marketing Authorisation Application under Accelerated Assessment for leniolisib 2022-10-28 13:00
Acceptance Of The Application For Clinical Trial Of Recbio Novel Adjuvanted Recombinant Quadrivalent HPV Vaccine 2022-10-28 11:10
Sebela Pharmaceuticals® Acquires Exclusive Licensing Rights to Develop and Commercialize Tegoprazan in the U.S. and Canada 2022-10-28 09:00
Sciwind Biosciences Announces Positive Interim Results from Ongoing Phase 2b Clinical Trial of XW003 (Ecnoglutide) in Patients with Obesity 2022-10-28 08:00
Life sciences industry's highest achievers celebrated at prestigious Awards ceremony 2022-10-27 22:39
1 56 57 58 59 60 229